There is general agreement that iatrogenic disease has increased over the past two decades, coincidentally with the growth of the pharmaceuticalindustry, the rising cost to the Exchequer of drugs used in the National Health Service, and with the increase in the proportion of potent drugs available. Publications on drug reactions are also increasing, and in the field of topical applications so-called 'overtreatment dermatitis' steadily gains in popularity as a diagnosis. Experience, however, teaches one to be wary of popular diagnostic labels and the self-satisfaction they may give to the physician. Drugs are almost invariably applied to the skin because of some pre-existing cutaneous lesion. If the skin condition worsens a diagnosis of overtreatment dermatitis all too often relieves the physician of the onus of diagnosing the primary lesion. Since most topical applications are used for the treatment of eczema or dermatitis (I use these terms synonymously), one should be consciously aware of the clinical behaviour of eczema. Two important characters of eczema are an inherent tendency to spread and a liability to relapses and recurrences, irrespective of how it is treated. When an eczema progresses adversely following local treatment, three possible causes should be considered. These are: (1) Intolerance of the skin lesion due to nonspecific physical factors and the heightened reactivity of the skin known as status eczematicus. (2) A specific delayed hypersensitivity reaction to one or more of the chemicals in the medicament. (3) Coincidental exacerbation of the eczema.
In my experience specific allergic sensitization (as shown by positive patch test) is responsible for less than half the adverse responses to topical medication. It is extremely difficult to evaluate the other two alternatives.
Accurate figures of the incidence of drug reaction of almost any type are virtually nonexistent, since mere numbers of cases are of little value unless they are related to the number of patients exposed to the drugs. For more than twenty years now all patients with an eczematous eruption attending the Finsen Institute in Copenhagen have been patch tested to a standard series of contact allergens including a number of drugs used on the skin. A recent analysis of the trends in positive reaction to these agents by P V Marcussen (personal communication 1961) has shown a decrease in sensitivity to turpentine, quinine, iodine, silver nitrate and resorcin; and a rise with tar, balsam of Peru, lanolin and formalin. Some of the substances such as formalin and lanolin may primarily sensitize the skin as a result of non-therapeutic exposure. Cross-sensitization or secondary reactions to chemicals used in articles of clothing, cosmetics, hair preparations, or particular occupations are not uncommon.
Experience with contact dermatitis from drugs varies from one country to another, and from one area to another according to prescribing habits. Table 1 shows the incidence of allergic reactions to drugs which I have seen at the Institute of Dermatology from [1953] [1954] [1955] [1956] [1957] [1958] [1959] [1960] . A positive patch test was obtained in each case. In the total of 772 I have listed separately 175 reactions to chlorpromazine and 16 to antibiotics which were purely occupational contacts. These figures are similar to the results of other series, showing that antibiotics, local anmsthetics, and antihistamines are the major topical sensitizers. A recent one-year survey by Vickers (1961) in Sheffield showed 117 cases of contact dermatitis from medicaments confirmed by patch tests. Table 2 gives details of the antibiotics which produced sensitivity. Contact dermatitis from penicillin has now diminished as its topical use has decreased in favour of other preparations. Chloramphenicol is a relatively potent sensitizer in proportion to the amount used; most of my cases have resulted from its use in ear drops. Neomycin sensitivity is steadily increasing with its extending usage. The diagnosis is frequently missed because of two special factors pertaining to neomycin: (I) It is only absorbed through the unbroken skin surface just as it is from the intestinal tract. Hence, patch tests with the 0-25 % concentration in many pharmaceutical formulations may be negative; it should be raised to 10% or more, or applied to epidermis stripped of stratum corneum with scotch tape, or injected intradermally -0-05 ml of a 1 % solution (Calnan & Sarkany 1958) . (2) It is often combined with a corticosteroid which will tend to conceal the diagnosis and considerably depress or obliterate the patch test reaction. Allergic contact sensitivity to tetracycline and oxytetracycline must be extremely rare if it occurs at all. Reactions to a proprietary brand of oxytetracycline ointment are known but have been traced to the 3 % of paraben esters it contains and not to the antibiotic itself (Sarkany 1960). Local anisthetic preparations have been long regarded as potent sensitizers by dermatologists, who rarely prescribe them. The topically useful ones all belong to the '-caine' variety, and the antigenic determinant on their molecules is a para-amino group on the benzene ring (lignocaine, in spite of its name, has an entirely different chemical structure). Table 3 lists the substances incriminated in 74 patients. The principal ways in which these patients became sensitized were by ear drops, applications for ano-genital pruritus, and the use of topical anesthetics to the gums by dentists. Eckersley et al. (1960) have recently reported an incidence of 8 % sensitization reactions to pessaries containing amethocaine and amylocaine used by patients with trichomonas vaginitis. Perhaps because amethocaine is the most readily absorbed from the unbroken skin and mucosal surfaces it.is the most widely used, and therefore responsible for the largest numbei of cases. Reactions to this group of compounds is particularly important because of cross-sensitization to numerous other substances containing a para-amino group, which are in common use. These include 'hair dyes, sulphonamides, sunscreen agents, and azo dyes for textiles (especially synthetic fibres). Table 4 shows the various antihistamines for topical use which have produced sensitization in this series. Diphenhydramine (in calamine lotion or as a cream) is a frequently prescribed topical antihistamine in Britain. Promethazine cream is very widely used in France and tops the list of sensitizers there; it has the added disadvantage of producing photosensitivity. One intriguing aspect of contact reactions to antihistamines is that there is no valid rationale for their use in eczema and little convincing evidence that they are of any value in its treatment whether administered locally or systemically.
Histamine is not tlhouglht to be an important chemical mediator in most eczema reactions.
The largest group of sensitizers in Table 1 have been classed as antibacterial agents, other than antibiotics; they are shown in Table 5 . Mercurial compounds (63), chloroxylenol (53), acriflavine (23) and sulphonamides (17) are the four major substances responsible; again the order may reflect a comparison of their usage, rather than graded differences in sensitizing properties. With the continuous development of new antibacterial substances it is likely that the use of mercurials on the skin will progressively diminish, especially with a greater awareness of the risks of absorption and doubts as to its benefits in psoriasis, eczema, lichen planus or other dermatoses. Three cases of thiomersal sensitivity are included in the has claimed that thiophenol in thiosalicylic acid and not the metallic ion is the antigenic determinant. Chloroxylenol is a frequent sensitizer, and some cases undoubtedly originate in the use of undiluted high concentrations of it on the skin. Cetrimide, domiphen and chlorhexidine require some comment. Acute reactions sometimes follow the use of these compounds suggesting allergic hypersensitivity. Cruikshank & Squire (1949) described 14 cases of allergy to cetrimide on the evidence of positive patch tests to a 1% solution. However, I have carried out an extensive series of tests on control eczema patients and frequently had positive reactions at a 1% and 0-1% concentration, when free exposure to the skin with such a solution (without occlusion) caused no ill effects. I believe that most, if not all, of the clinical reactions to this group of compounds, of which cetrimide is the most widely used, are not manifestations of specific allergic sensitivity but may be caused by mechanisms analogous to that involved in acute reactions to detergents, lauryl sulphate and so on.
Details of the miscellaneous group of sensitizers not previously mentioned are shown in Table 6 . A few of them are worthy of comment. Colophony resin is the chief sensitizer in adhesive plasters. Lanolin is used in the bases of many ointments. It is likely that a number of cases of lanolin sensitivity are missed for three reasonslanolin is not a pure chemical and specimens vary in composition according to the source; the actual allergen may make up less than 1 % of the whole; and measures to facilitate penetration of the allergen may be required in patch testing (Hjorth 1961 , personal communication, Everall et al. 1954 . Balsam of Peru used to be a frequent cause of reactions to tulle gras, but it was omitted by the principal manufacturers some years ago following reports of contact dermatitis (Ridley 1957 , Trevethick 1957 . The estimated annual importation into Britain is still between 10 and 12 tons. It is widely used in Denmark as a household remedy for minor injuries, and sensitization reactions there are common. Again it is important as a cross-sensitizer with perfumes, flavouring agents, spices, orange peel and other substances (Hjorth 1961) .
It is important to appreciate that pure substances are rarely applied by themselves to the skin. Apart from the vehicle, which may itself consist of more than one substance or contain impurities or be of inconstant composition, polypharmacy is as popular as ever. Sometimes minor constituents are not indicated in the title of the preparation, or are written on the label in such small print as to escape notice. Two other facets of contact sensitization with drugs deserving of mention are dermal reactions and photosensitivity. Epstein (1958) put forward the view that there is a special type of papular contact dermatitis, in which patch tests are negative but intradermal tests with the allergen are positive, and that this has a different immunological basis from the usual contact dermatitis reaction. His thesis has not, as yet, received wide support. Photosensitivity as a result of the topical application of a drug known as photocontact dermatitis, has increased considerably in recent years. It was very frequent with sulphonamides amongst troops in the Mediterranean theatre during World War II. More recently the phenothiazine derivatives (especially promethazine hydrochloride and chlorpromazine) and tetrachlorosalicylanide (a soap germicide) have become prominent in this regard (Wilkinson 1961 a,b) .
A discussion on contact dermatitis from drugs raises many problems of the biological behaviour of the skin, cutaneous absorption, genetics, immunology, chemistry, and legislation. Bruno Bloch, and later Rostenberg (1957) , have tried to express in a formula' the factors determining why an individual becomes sensitized to a contactant. One of the few measurable factors is the concentration of the drug; sensitizing power is directly proportional to it. The best way to reduce the incidence of reactions is to use the minimal concentration necessary for the minimal period of time. The strength of drugs in eardrops is often unnecessarily high. Apart from the concentration of the substance and the manner of its percutaneous absorption, trauma to the skin surface, seasonal and climatic changes, and previous environmental exposure to the allergen are all relevant. Some disruption of the integrity of the barrier layer of the stratum corneum is necessary to initiate sensitization with the majority of drugs in common use, and presumably the eczema process facilitates reactions to medicaments by this mechanism as well as making absorption easier. Most physicians agree that reactions to drugs are commoner on eczematous skin; since drugs are used so little on normal skin, this is difficult to prove. Examples of crosssensitivity steadily multiply. Some chemical configurations are notoriously potent sensitizers, such as para-amino,and thiol groups, hydrazines and halogenated nitrobenzenes. Although these substances may not be used themselves, derivatives are sometimes mistakenly regarded as safe. Furthermore, because of the different immunological mechanism involved, drugs which rarely cause reactions when administered systemically may be potent contact sensitizers. Examples are hydrallazine, isoniazid and dimercaprol. Legislation is not the most desirable means of drug control, and experience has shown that the Food, 1 Gf x Aq ;>-K =S where G ==the genetic make-up of the host A=the intrinsic allergenicity of the compound f=adventitious factors which may influence the sensitizability of the host at that time q =quantitative factors K=some theoretical level which the product of Gf x Aq must reach in order for a sensitization to be detectable clinically S=detectable sensitivity (Rostenberg 1957) Drug and Cosmetics Act of the United States does not prevent sensitizing compounds from reaching the market. This is partly because efficient means to identify such compounds have not yet been devised. However, two experiences of prophylactic legislation are of some interest. Paraphenylenediamine is not permitted to be used in Denmark, and cases of sensitivity to this compound are extremely rare, in contrast to their frequency in other countries (Hjorth 1960, personal communication) . In 1958 the use of ammonium persulphate in bread was forbidden in Western Germany. Since that time bakers' dermatitis has virtually disappeared (Preyss 1960) .
Skin Reactions to Ingested Drugs by S C Gold MA MD FRCP (London) My approach to this somewhat overwhelming subject can only be clinical; I have nothing new to describe and shall confine myself to the problems as they present in the wards and clinics.
Skin eruptions provoked by drug ingestion have been long recognized and while it is probably true to say that no drug exists which at some time or another may not provoke a skin reaction in a susceptible person, there are certainly many drugs which are peculiarly liable to do so. When one considers the increasing number of chemicals flowing on to the market to become available for medical use it is obviously trite to say that one must ever be alert for new and unsuspected drug reactions. A current list of those commonly causing trouble in 1961 would surely be headed by penicillin and followed by the sulphonamides, barbiturates, other antibiotics, antituberculous drugs, carbromal and phenolphthalein. A list made, for instance, in 1931 would have included gold, arsenic, mercury, phenazone, bromides and iodides. Presumably, thirty years hence the troublemakers will again be different.
The skin as the target for such inflammatory
